• Roger G. Pertwee

Part of the Handbook of Experimental Pharmacology book series (HEP, volume 231)

Table of contents

  1. Front Matter
    Pages i-xii
  2. Maria Grazia Cascio, Pietro Marini
    Pages 39-58
  3. Guy A. Cabral, Gabriela A. Ferreira, Melissa J. Jamerson
    Pages 185-211
  4. TIziana Rubino, Erica Zamberletti, Daniela Parolaro
    Pages 261-283
  5. Natalia Battista, Monica Bari, Mauro Maccarrone
    Pages 341-365
  6. Blandine Gatta-Cherifi, Daniela Cota
    Pages 367-391
  7. Saoirse Elizabeth O’Sullivan
    Pages 393-422
  8. Angelo A. Izzo, Giulio G. Muccioli, Michael R. Ruggieri, Rudolf Schicho
    Pages 423-447
  9. Guillermo Velasco, Cristina Sánchez, Manuel Guzmán
    Pages 449-472
  10. Back Matter
    Pages 473-475

About this book


There is currently considerable interest in the development of medicines that would enhance endocannabinoid-induced “autoprotection”, for example through inhibition of endocannabinoid metabolizing enzymes or cellular uptake processes or that would oppose endocannabinoid-induced “autoimpairment”. This volume describes the physiology, pathophysiology and pharmacology of the endocannabinoid system and potential strategies for targeting this system in the clinic.


anandamide and 2-arachidonoyl glycerol cannabinoid receptors central and peripheral disorders endocannabinoid physiology endocannabinoids pathophysiology and pharmacology

Editors and affiliations

  • Roger G. Pertwee
    • 1
  1. 1.Professor of NeuropharmacologyUniversity of Aberdeen Institute of Medical SciencesAberdeenUnited Kingdom

Bibliographic information